Investors scrap for Teva Pharmaceutical bonds
July 22, 2016 at 10:31 AM EDT
NEW YORK, July 22 (IFR) - Teva Pharmaceutical raised more than US$20bn across three currencies this week via an acquisition-driven bond that took advantage of pent-up demand for corporate paper in a yield-starved market.
